WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] Voir le document au format PDF
Table des matières
Afficher le documentPreface
Afficher le documentIntroduction
Ouvrir ce répertoire et afficher son contenuParasitic infections
Ouvrir ce répertoire et afficher son contenuInsect and arachnid bites and stings
Ouvrir ce répertoire et afficher son contenuSuperficial fungal infections
Ouvrir ce répertoire et afficher son contenuSubcutaneous fungal infections
Ouvrir ce répertoire et afficher son contenuBacterial infections
Ouvrir ce répertoire et afficher son contenuViral infections
Ouvrir ce répertoire et afficher son contenuEczematous diseases
Ouvrir ce répertoire et afficher son contenuScaling diseases
Ouvrir ce répertoire et afficher son contenuPapulosquamous diseases
Afficher le documentCutaneous reactions to drugs
Ouvrir ce répertoire et afficher son contenuPigmentary disorders
Ouvrir ce répertoire et afficher son contenuPremalignant lesions and malignant tumours
Ouvrir ce répertoire et afficher son contenuPhotodermatoses
Ouvrir ce répertoire et afficher son contenuBullous dermatoses
Afficher le documentAlopecia areata
Afficher le documentUrticaria
Ouvrir ce répertoire et afficher son contenuConditions common in children
Afficher le documentAcne vulgaris
Afficher le documentPruritus
Afficher le documentTropical ulcers
Ouvrir ce répertoire et afficher son contenuAntimicrobial drugs
Ouvrir ce répertoire et afficher son contenuAntifugal drugs
Ouvrir ce répertoire et afficher son contenuAntiseptic agents
Ouvrir ce répertoire et afficher son contenuKeratoplastic and keratolytic agents
Ouvrir ce répertoire et afficher son contenuScabicides and pediculicides
Ouvrir ce répertoire et afficher son contenuAnti-inflammatory and antipruritic drugs1
Ouvrir ce répertoire et afficher son contenuAntiallergics and drugs used in anaphylaxis
Ouvrir ce répertoire et afficher son contenuUltraviolet radiation-blocking agents (sunscreens)
Ouvrir ce répertoire et afficher son contenuMiscellaneous drugs
Ouvrir ce répertoire et afficher son contenuAnnex
Afficher le documentSelected WHO Publications of Related Interest
Afficher le documentBack cover
 

Cutaneous reactions to drugs

The incidence of cutaneous reactions to drugs is difficult to determine, but as multiple drug use increases, it is likely that the incidence of reactions to drugs will also increase. Therefore, in examining patients with skin diseases, it is important to consider the possibility that the patient has a drug eruption.

Drug eruptions may follow the use of topically or systemically administered drugs. A reaction to a topically applied drug should be considered whenever there is a sudden worsening of a dermatitic reaction at a time when the patient should be improving. It is important to realize that drug eruptions can even be caused by topical drugs that are usually of value in treating dermatitis, such as hydrocortisone. Reactions can also occur to topically applied antihistamines. Drug eruptions from topical agents can be allergic in nature or result from a primary irritant reaction.

The majority of cutaneous reactions to drugs follow the use of systemically administered drugs, and here the reaction pattern may be localized to the skin or involve various organ systems. The mechanism underlying a cutaneous reaction to a drug may involve the immune system, but it is much more likely that it will be non-immunological. Non-immunological mechanisms might include direct toxicity, intolerance, pharmacological responses, idiosyncratic responses, metabolic alterations, and drug interactions. In many instances the mechanism is never determined. The lesions associated with drug eruptions are protean in nature and can extend from a barely perceptible morbilliform erythematous eruption to a generalized, life-threatening exfoliative erythroderma or toxic epidermal necrolysis. The mucous membranes may or may not be involved. Phototoxic drug eruptions are common. Specific reaction patterns may be seen, such as an acneiform or lichen planus-like drug reaction.

In the vast majority of cases, laboratory tests are not useful and the key to the diagnosis is an awareness that a drug may be causing the reaction pattern. Anticonvulsants, psycho-therapeutic drugs, analgesics, antimicrobials, antineoplastic agents, cardiovascular drugs and diuretics are among the drugs frequently cited as the causes of adverse reactions. Standard dermatological texts contain lists of drugs that are most likely to produce certain reaction patterns.

Management

Obviously the suspect drug(s) should be stopped, particularly if the drug eruption is severe. In some mild drug reactions, it may be possible to continue the drug if it is medically necessary. Treatment is symptomatic, and in mild reactions may not be necessary. However, with severe drug reactions such as exfoliative dermatitis and generalized bullous reactions, systemic corticosteroids may be required.

 

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 24 avril 2012